| Identification | Back Directory | [Name]
Nelipepimut-S | [CAS]
160212-35-1 | [Synonyms]
NeuVax E75 peptide Nelipepimut-S NeuVax vaccine L-Leucine, L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl- | [Molecular Formula]
C50H78N10O11 | [MOL File]
160212-35-1.mol | [Molecular Weight]
995.21 |
| Hazard Information | Back Directory | [Uses]
Nelipepimut-S is a peptide vaccine which targets HER2. Nelipepimut-S has immune activity against HER2 positive breast cancer[1]. | [IC 50]
HER2 | [References]
[1] Dillon PM, et al. Evaluating Nelipepimut-S in the Treatment of Breast Cancer: A Short Report on the Emerging Data. Breast Cancer (Dove Med Press). 2020 Apr 3;12:69-75. |
|
| Company Name: |
YantaiBio
|
| Tel: |
13758194781 15083780366 |
| Website: |
|
|